Shankar Lanke

Shankar Lanke

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4403786
-
person_outline Shankar Lanke's MOST POPULAR ARTICLES
1-) AUC‐guided vancomycin dosing in adolescent patients with suspected sepsis The Journal of Clinical Pharmacology 57 (1), 77-84, 2017
2-) Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV‐infected Ugandans HIV medicine 13 (4), 193-201, 2012
3-) AUC‐guided vancomycin dosing in adolescent patients with suspected sepsisS Lanke, T Yu, JE Rower, AH Balch, EK Korgenski, CM SherwinThe Journal of Clinical Pharmacology 57 (1), 77-84, 2017332017
4-) Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix systemSSS Lanke, SG Gayakwad, JG Strom, MJ D\'souzaJournal of microencapsulation 26 (6), 493-500, 2009322009
5-) Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV‐infected UgandansS Nanzigu, J Eriksen, F Makumbi, S Lanke, M Mahindi, R Kiguba, O Beck, ...HIV medicine 13 (4), 193-201, 2012242012